Vinblastine
Links shared publicly online about this topic
Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. - Full Text View - Clinica
clinicaltrials.gov — “Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment. - Full Text View - ClinicalTrials.gov” View full resource at clinicaltrials.gov
Most Recently Shared on January 8, 2010 at 3:46 am By:
Trial for refractory Hodgkin Lymphoma pts at Mayo Clinic. http://bit.ly/4MRM8A
Oncology Medical News about Lymphoma
mdlinx.com — “Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas” View full resource at mdlinx.com
Most Recently Shared on June 17, 2010 at 11:10 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, ... http://bit.ly/d4HmoQ #oncology
Cholesterol derived from LDL acts as a chemosensitizer in multidrug resistant lymphoblastic leukemia cells. | GreenMedInfo | Article | Natural Medicine | Alternative Medicine
greenmedinfo.com — “This article on GreenMedInfo.com concerns - Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.” View full resource at greenmedinfo.com
Most Recently Shared on February 20, 2011 at 5:24 am By:
Sayer Ji CAM and Health Advocate
The close connection between lower cholesterol, statin drug use and higher rates of cancers in those who use them,... http://fb.me/VG050aKj
Comparison of Two Intensified Regimens in Advanced Urothelial Cancer: A Prospective, Randomized, Phase 3 Study - MPR
empr.com — “Dose dense (DD) gemcitabine/cisplatin therapy was not superior to DD methotrexate/vinblastine/doxorubicin HCl/cisplatin in patients with inoperable or recurrent urothelial cancer; however, the former was better tolerated, results of a Phase 3 randomized trial presented at the American Society of Clinical Oncology’s 2011 Annual Meeting have found.” View full resource at empr.com
Most Recently Shared on June 6, 2011 at 7:42 pm By:
MPR News: Comparison of Two Intensified Regimens in Advanced Urothelial Cancer: A Prospective, Randomized, Phase... http://bit.ly/l0hZOk
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Lymphomation.org
Lymphomation.org/Patients Against Lymphoma -- Providing support and timely access to evidence-based information on lymphomas and their treatment.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sayer Ji
Sayer Ji is the creator of GreenMedInfo.com, the world's largest open source and entirely evidence-based natural medical resource. He is a health researcher and writer whose work has been published in the Journal of Gluten Sensitivity, The Well-Being Journal and The Dot Connector. He is the Nutrition Director a the Naples Birth Center and Nutrition Educator for For Goodness Sake Organic Markets. Sayer is a Rutgers graduate with a background in philosophy and psychology.
Advertisement
